Kira Pharmaceuticals raises a $53,500,000 series B round from APlus Partners, Foresite Capital, QiMing Venture Partners, Quan Capital, RA Capital Management and Vivo Capital.
Kira Pharmaceuticals raises a $46,000,000 series A round from 6 Dimensions Capital, QiMing Venture Partners, Quan Capital and Sinopharm Capital.
Documentaries, videos and podcasts
February 23, 2021
/PRNewswire/ -- Kira Pharmaceuticals, a global biotechnology company pioneering a new generation of complement-targeted therapies to treat immune-mediated...